Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115088
Chunk: 340

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 340
---
 surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding awards or substitute similar awards for such outstanding awards. |

**Equity Award Timing Procedures In accordance with Item 402(x) of Regulation S-Kunder the Securities Act, we are providing information regarding our procedures related to the grant of certain equity awards close in time to the release of material non-publicinformation (“MNPI”). We generally grant equity awards annually, and any such equity awards granted are recommended by the Compensation Committee and approved by our Board on or before the grant date. We do not grant equity awards in anticipation of the release of material non-publicinformation and do not time, and do not plan to time, the release of material non-publicinformation in coordination with grants of equity awards in a manner that intentionally affects the value of executive compensation. Additionally, our Insider Trading Policy prohibits directors, officers and employees from trading in our common stock while in possession of or on the basis of MNPI about us. We have not timed, and do not plan to time, the disclosure of MNPI for the purpose of affecting the value of executive compensation. In the year ended December 31, 2024, no options were granted to our named executive officers within four business days prior to, or one business day following, the filing or furnishing of a periodic or current report by us that disclosed MNPI. Equity-Based Incentive Plans 2017 Scilex Pharmaceuticals Inc. Equity Incentive Plan In June 2017, our Board adopted the Scilex Pharma 2017 Plan. In connection with the corporate reorganization in March 2019, the Scilex Pharma 2017 Plan was terminated. Accordingly, after such time, no additional awards were granted under the Scilex Pharma 2017 Plan. Scilex Holding Company 2019 Stock Option Plan In May 2019, our Board adopted the 2019 Stock Option Plan, which subsequently was amended in December 2020. The 2019 Stock Option Plan was terminated at the closing of the Business Combination, and no further awards have been granted under the 2019 Stock Option Plan thereafter. However, the 2019 Stock Option Plan will continue to govern outstanding awards granted thereunder. Scilex Holding Company 2022 Equity Incentive Plan In October 2022, our Board adopted the Equity Incentive Plan. The total number of shares of Common Stock for which incentive stock options (“ISOs”) may be granted under the Equity Incentive Plan